We use cookies to improve the function of this site and enhance the user experience.
Learn more about our cookie policy and how to modify your cookie settings.
UK/CORP/15-0012l. Date of preparation: July 2015
United Kingdom
Search    
Include All CSL Behring Country Sites

UK Statement on Anti-Slavery

CSL Behring UK Limited is part of the global CSL Behring organisation. CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself. Our products are produced at facilities in Bern, Switzerland; Marburg, Germany; Kankakee, Illinois and Broadmeadows, Australia. The UK Company uses distribution partners to supply our products to customers.

The global CSL Behring organisation has a Code of Responsible Business Practice which sets out the measures we take to ensure we conduct business ethically and responsibly, for the benefit of patients, employees, customers, suppliers and other parties who are involved with the production and supply of our products. The UK business has a supporting policy which strictly prohibits the use of slavery or human trafficking within the business or in our direct supply chain, in accordance with the UK Modern Slavery Act 2015.

We undertake all reasonable and practical steps to ensure that our standards are implemented and that local legislation and regulations are being complied with, both throughout our business and within our direct supply chain. We will only work with those parties who fully comply with these standards with issues of non-compliance being dealt with on a case by case basis.

CSL Behring is a subsidiary of CSL Limited. CSL Limited will publish a modern slavery statement in its global Corporate Responsibility Report in December 2016. The statement will be made available on our website.

UK/CORP/15-0012q Date of preparation: August 2016